HC SURGICAL SPECIALISTSLIMITED (1B1) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of HC SURGICAL SPECIALISTSLIMITED stock S$0.71, price S$0.35, upside +102.9%, quality 83 out of 100. Rating: strongly undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
HC SURGICAL SPECIALISTSLIMITED
1B1 · SGCheap (51% below fair value), strong company and rising price: meets all 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range 0.2149 SGD – 0.4439 SGD · fair‑value band 0.5000 SGD – 0.9000 SGD · the 0.3500 SGD price screens below the 0.7100 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether HC SURGICAL SPECIALISTSLIMITED is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics.
Show moreShow less
It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services.
In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections.
Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services.
Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.
Stock analysis
HC SURGICAL SPECIALISTSLIMITED (1B1) currently trades at 0.3500 SGD, while our model-based Fair Value estimate is 0.7100 SGD, implying the stock looks roughly 51% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 0.9900 SGD per share, and 20 of the 24 models we run sit above the 0.3500 SGD price.
Bear case: the Dividend Discount group reads lowest at 0.2150 SGD, and 4 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: 0.5000 SGD (bear) to 0.9000 SGD (bull), the price of 0.3500 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 83/100 (high quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
HC SURGICAL SPECIALISTSLIMITED reported revenue of 19.1M SGD in FY2025 versus 23.4M SGD in FY2021, a compound −4.9%/yr. Reported net income was 8.4M SGD in FY2025, compounding +1.3%/yr from FY2021.
Key figures
Market cap 53.7M SGD (≈ $41.7M) Micro · P/E ratio 7.0 · P/S ratio 2.71 · EPS (TTM) 0.0500 SGD · Dividend yield 6.0% · Net margin 35.3% · Return on equity 34.8% · Return on assets (EBIT) 26.2% (4-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 87 out of 100 (low confidence).
What moves the price
The share trades about 13% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at 103%, 1B1 screens cheaper than that median.
Fair Value models
All 24 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 1B1, get fair value alerts →
Compare HC SURGICAL SPECIALISTSLIMITED with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- Piotroski F-Score screener with fair value
- Valuation of the Singapore market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs 1B1 |
| IQVIA Holdings IQV | $265.12 | $291.63 | +10% | vs 1B1 |
| Illumina, Inc ILMN | $207.01 | $227.71 | +10% | vs 1B1 |
| Thermo Fisher Scientific Inc TMO | $700.22 | $686.04 | −2% | vs 1B1 |
| Danaher Corporation DHR | $233.02 | $209.18 | −10% | vs 1B1 |
| IDEXX Laboratories, Inc IDXX | $704.23 | $496.48 | −30% | vs 1B1 |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs 1B1 |
| Mettler-Toledo International Inc MTD | $1,739 | $655.06 | −62% | vs 1B1 |
| Agilent Technologies, Inc A | $173.96 | $64.53 | −63% | vs 1B1 |
| Waters Corporation WAT | $460.25 | $91.26 | −80% | vs 1B1 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is HC SURGICAL SPECIALISTSLIMITED (1B1) overvalued or undervalued?
What is the fair value of 1B1?
What is the quality score of 1B1?
What is the price target for HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the HC SURGICAL SPECIALISTSLIMITED stock forecast for 2026?
What is the revenue of HC SURGICAL SPECIALISTSLIMITED (1B1)?
Does HC SURGICAL SPECIALISTSLIMITED pay a dividend?
How much is the dividend of HC SURGICAL SPECIALISTSLIMITED (1B1) and when is the ex-dividend date?
What growth is priced into HC SURGICAL SPECIALISTSLIMITED (1B1)?
What discount rate (WACC) does the fair value of 1B1 use?
What is a reverse DCF?
How much growth has HC SURGICAL SPECIALISTSLIMITED (1B1) delivered so far?
How fast is the sector of HC SURGICAL SPECIALISTSLIMITED (1B1) growing?
What is the free cash flow yield of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the intrinsic value of HC SURGICAL SPECIALISTSLIMITED (1B1)?
Is HC SURGICAL SPECIALISTSLIMITED stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 1B1?
How much is HC SURGICAL SPECIALISTSLIMITED worth?
What do the bullish and bearish scenarios say about 1B1?
What is the P/E ratio of 1B1?
How solid is the balance sheet of HC SURGICAL SPECIALISTSLIMITED (1B1)?
How far is 1B1 from its 52-week high?
Which stocks are comparable to HC SURGICAL SPECIALISTSLIMITED?
Is HC SURGICAL SPECIALISTSLIMITED stock attractive at the current price?
How is the fair value of 1B1 calculated?
Is it still worth investing in stocks now?
What is the share price of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What should I pay attention to with HC SURGICAL SPECIALISTSLIMITED right now?
Key figures of HC SURGICAL SPECIALISTSLIMITED
How large is the market capitalisation of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the P/S ratio of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What are the earnings per share of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the dividend yield of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the net margin of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the return on equity of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the EBIT return on assets of HC SURGICAL SPECIALISTSLIMITED (1B1)?
What is the operating margin of HC SURGICAL SPECIALISTSLIMITED (1B1)?
How fast is revenue growing at HC SURGICAL SPECIALISTSLIMITED (1B1)?
How fast are earnings growing at HC SURGICAL SPECIALISTSLIMITED (1B1)?
Watch HC SURGICAL SPECIALISTSLIMITED in the live analysis
One click puts HC SURGICAL SPECIALISTSLIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.